Can you talk about some of the areas that Celesta is interested in?

Celesta has three areas of focus in its investments. Number one is what we call platforms enabling mass adoption of emerging technologies. Number two is what we call technologies transforming large industries, technology-enabled transformation. And the third is healthcare innovations at the intersection of high tech and biotech.

First one, we usually call deep tech. Second one, we call technology-enabled transformation. The third, we call bioconvergence. Those are the three areas in which we are very keenly focused.

‍

Can you walk us through the Celesta model? What is the way in which you approach investing in these companies? How closely do you like to work with them? What stages, and for how long?

First of all, a lot of interesting opportunities are brought to us from people in our networks. We see ourselves as active investors, so we most often lead the deal. We will almost always participate on the board. When required for the success of the company, we're happy to have more than one person on the board. There are times when we have had up to three people on the board.

We are generally active investors trying to help our companies succeed. How does that happen? One, the amount of experience that our folks have, I think there are very few firms that have this breadth and length of experience that our partners have. Second, the technical insights of our partners are often very deep. Third, they can help open doors and make connections that are very valuable to a young company.